Specialists often choose brand-name drugs over generics because of clinical risks, complex patient needs, and a broken pricing system that rewards high-cost drugs. Here's why the trend persists-and who's really paying the price.
Specialists often choose brand-name drugs over generics because of clinical risks, complex patient needs, and a broken pricing system that rewards high-cost drugs. Here's why the trend persists-and who's really paying the price.
Pharmaceuticals
